Sharon Fenick
110 IP cases indexed. Covers patent matters.
Cases Presided Over
110 cases indexed | Page 2 of 4
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s IPR resulted in the Board finding all six challenged claims of Omni MedSci’s ’299 patent unpatentable as obvious over a combination of prior‑art references covering wearable optical sensing.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
The PTAB issued a Final Written Decision in IPR2021‑00453, finding claims 1,2,7 and 15‑23 of Omni MedSci’s wearable pulse‑oximeter patent unpatentable over prior art, while leaving the remaining claims intact.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s IPR against Omni MedSci’s wearable physiological measurement patent resulted in all challenged claims being held unpatentable. The Board found the claims obvious over Lisogurski, Carlson, and Mannheimer under §103(a).
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s inter‑partes review of Omni MedSci’s ’533 patent resulted in the PTAB finding all challenged claims unpatentable for obviousness over Lisogurski, Carlson, and Mannheimer.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple won a PTAB IPR against Omni MedSci, finding 12 of the 23 challenged claims of the 10,517,484 B2 wearable health‑monitoring patent unpatentable, while the remaining claims survived.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s IPR against Omni MedSci’s wearable health‑monitoring patent resulted in the Board finding all challenged claims unpatentable as obvious over a combination of prior‑art references.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple (as petitioner) secured a Final Written Decision finding claims 1,2,7,15‑23 of Omni MedSci’s wearable health‑monitoring patent unpatentable as obvious over prior‑art. The Board affirmed the petitioner's obviousness arguments while leaving claims 3‑6 and 8‑14 intact.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s petition succeeded; the PTAB held all challenged claims of Omni MedSci’s wearable physiological measurement patent unpatentable as obvious over Lisogurski, Carlson, and Mannheimer references.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
The PTAB issued a Final Written Decision on remand, holding that all 23 claims of Omni MedSci’s wearable pulse‑oximeter patent are unpatentable. The Board relied on an obviousness analysis over a combination of prior‑art references and affirmed the claim construction of “identify an object.”
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
The PTAB issued a Final Written Decision on Remand, finding all 23 claims of Omni MedSci’s wearable pulse‑oximeter patent unpatentable. Apple’s arguments on obviousness over multiple prior‑art references prevailed.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple prevailed in an IPR against Omni MedSci, finding claims 7 and 10‑14 of the ’299 patent unpatentable for obviousness over Lisogurski, Carlson, Mannheimer, and Park references.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
The PTAB held that Samsung’s challenge to Omni MedSci’s wearable physiological monitoring patent succeeded on 12 of the 23 claims, finding them obvious over prior‑art references such as Lisogurski, Carlson, Tran, Isaacson and Valencell‑093. The remaining claims were not shown unpatentable.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s IPR against Omni MedSci’s ‘533 patent resulted in all challenged claims being found unpatentable. The Board held that the claims were obvious over prior‑art references Lisogurski, Carlson, and Mannheimer.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s wearable physiological‑monitoring patent was declared entirely unpatentable after Samsung’s PTAB challenge, with the Board finding the claims obvious over a combination of prior‑art references covering optical sensors, pulse‑rate modulation, spaced emitters, and reflective surfaces.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple’s IPR against Omni MedSci’s wearable health monitoring patent concluded with the Board finding all 23 claims unpatentable for obviousness. The decision affirmed the claim construction of “identify an object” and rejected the need for further briefing.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple prevailed in IPR2020‑00175, with the PTAB finding all six challenged claims of the ’299 patent unpatentable as obvious over Lisogurski, Carlson, Mannheimer and Park references.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple prevailed in an IPR against Omni MedSci’s wearable health‑monitoring patent, finding 12 of the 23 claims unpatentable while the remaining claims survived.
SAMSUNG ELECTRONICS CO., LTD. et al. v.OMNI MEDSCI, INC.
Apple (as petitioner) prevailed in an IPR against Omni MedSci’s 9,651,533 patent, with the PTAB finding all challenged claims unpatentable as obvious over Lisogurski, Carlson, and Mannheimer. The decision hinges on pulse‑rate and signal‑to‑noise teachings in the prior art.
LG ELECTRONICS, INC. et al. v.Multimedia Technologies Pte. Ltd.
VIZIO successfully convinced the PTAB that MULTIMEDIA TECHNOLOGIES PTE. LTD.'s claims related to VOD user interfaces were obvious over prior art references. The Board found that combining existing concepts from sources like TechnoBuffalo and Kim provided sufficient motivation for a Person Having Ordinary Skill in the Art (POSITA).
Samsung Electronics Co., Ltd. et al. v.Empire Technology Development LLC
Samsung Electronics successfully petitioned for IPR against Empire Technology Development's patent, arguing that the claims are obvious over prior art. The Board preliminarily adopted a broad definition of 'idle power consumption,' setting the stage for a detailed examination of technical combination possibilities.
Samsung Electronics Co., Ltd. et al. v.Empire Technology Development LLC
The PTAB found claims 25-28 unpatentable over Li and Siam, based on obviousness (103). The Board adopted a specific construction of 'idle power consumption' as power consumed while powered on and waiting to send data. However, the attempt to prove obviousness for claim 29 failed due to impermissible hindsight bias.
Roku, Inc. v.Dolby International AB
Roku, Inc.'s IPR challenge against Dolby International AB's audio signal coding patents was denied by the PTAB. The Board found that Roku failed to establish a reasonable likelihood of prevailing on any obviousness grounds (35 U.S.C. § 103).
Genius Sports v.SportsCastr Inc.
The PTAB institution decision granted IPR against claims 16-30 of the '218 patent, finding sufficient evidence to overcome initial defenses. The Board found that Petitioner successfully demonstrated a rationale for combining prior art references (Ellis and Spivey) to meet the institutional standard for obviousness.
Genius Sports Ltd. v.SportsCastr Inc.
The PTAB institution decision was granted, finding sufficient rationale for the Petitioner to combine teachings from prior art references (Ellis and Spivey) under 35 U.S.C. § 103. The Board specifically found that combining Ellis's content source with Spivey’s live data server devices would improve latency in real-time event delivery.
Genius Sports Ltd. v.SportsCastr Inc.
Genius Sports Ltd. successfully convinced the PTAB to institute IPR proceedings against SportsCastr Inc. d/b/a PANDA Interactive regarding live event broadcasting claims. The Board accepted the Petitioner's arguments that the claimed technology is obvious over combinations of prior art references, including Ellis and Spivey. This sets the stage for a full trial on unpatentability grounds.
Genius Sports Ltd. v.SportsCastr Inc.
Genius Sports Ltd. successfully convinced the PTAB that its claims relating to live event content delivery systems are likely unpatentable over combinations of prior art references (Ellis, Spivey, Herzog). The Board found a reasonable likelihood of success regarding obviousness for multiple claims, leading to institution.
Genius Sports Ltd. v.SportsCastr Inc.
The PTAB institution decision found reasonable likelihood of unpatentability for Genius Sports Ltd.'s claims against SportsCastr Inc. The Board determined that the combination of prior art references (Ellis, Spivey, Herzog) taught or suggested all limitations of Claim 1 and its dependents based on the preliminary record. This sets a significant hurdle for SportsCastr's patent validity in digital media streaming technology.
Genius Sports Ltd. v.SportsCastr Inc.
Genius Sports Ltd. successfully convinced the PTAB to institute proceedings against SportsCastr Inc., finding a reasonable likelihood of prevailing on at least one claim. The Board found that claims 1-9 were obvious over combinations of prior art references, specifically demonstrating how known techniques could reduce data latency in live sports content delivery.
Thermaltake Technology Co., Ltd. et al. v.Chen, Chien-Hao et al.
The PTAB instituted the IPR, finding a reasonable likelihood of unpatentability for at least one claim based on obviousness. The Board specifically found evidence supporting Claim 1 over Lai and Hasegawa, while also noting inconclusive findings regarding Tsuji/Huang combinations.
Thermaltake Technology Co., Ltd. et al. v.Chen, Chien-Hao et al.
The Board found that all originally challenged claims (1-5) were unpatentable under 35 U.S.C. § 103 based on prior art combinations. Furthermore, the Patent Owner's Revised Motion to Amend was denied because proposed substitute claims lacked written description support for a key limitation.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.